MORRISVILLE, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (organisme commercial sous contrat), today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the Baird 2020 Global Healthcare conference on septembre 9, 2020, at 8:30 a.m. ET.
A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and organisme commercial sous contrat (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Ensemble, nous partageons des connaissances, utilisons les dernières technologies et appliquons des pratiques commerciales de pointe pour accélérer la livraison d’importants traitements par nos clients aux patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Contacts
| Investor Relations: |
|
Press/Media: |
| Ronnie Speight |
|
Danielle DeForge |
| Senior Vice President, Investor Relations |
|
Executive Director, External Communications |
| +1 919 745 2745 |
|
+1 202 210 5992 |
| [email protected] |
|
[email protected] |
Source: Syneos Health, Inc.
